223 related articles for article (PubMed ID: 37430431)
1. Children's Oncology Group's 2023 blueprint for research: Cancer control and supportive care.
Esbenshade AJ; Sung L; Brackett J; Dupuis LL; Fisher BT; Grimes A; Miller TP; Ullrich NJ; Dvorak CC;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30568. PubMed ID: 37430431
[TBL] [Abstract][Full Text] [Related]
2. Children's Oncology Group's 2013 blueprint for research: cancer control and supportive care.
Sung L; Zaoutis T; Ullrich NJ; Johnston D; Dupuis L; Ladas E;
Pediatr Blood Cancer; 2013 Jun; 60(6):1027-30. PubMed ID: 23255159
[TBL] [Abstract][Full Text] [Related]
3. Children's Oncology Group's 2023 blueprint for research: Behavioral science.
Embry L; Bingen K; Conklin HM; Hardy S; Jacola LM; Marchak JG; Paltin I; Pelletier W; Devine KA
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30557. PubMed ID: 37430416
[TBL] [Abstract][Full Text] [Related]
4. Children's Oncology Group 2023 blueprint for research: Adolescent and young adult oncology.
Roth ME; Grimes AC; Reed DR; Weiss AR; Mittal N; Parsons SK; Freyer DR;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30564. PubMed ID: 37439574
[TBL] [Abstract][Full Text] [Related]
5. Children's Oncology Group's 2013 blueprint for research: adolescent and young adult oncology.
Freyer DR; Felgenhauer J; Perentesis J;
Pediatr Blood Cancer; 2013 Jun; 60(6):1055-8. PubMed ID: 23424167
[TBL] [Abstract][Full Text] [Related]
6. Children's Oncology Group's 2023 blueprint for research: Diversity and health disparities.
Winestone LE; Beauchemin MP; Bona K; Kahn J; Prasad P; Robles JM; Velez MC;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30592. PubMed ID: 37501542
[TBL] [Abstract][Full Text] [Related]
7. Children's Oncology Group's 2023 blueprint for research: Germ cell tumors.
Bhuta R; Shah R; Gell JJ; Poynter JN; Bagrodia A; Dicken BJ; Pashankar F; Frazier AL; Shaikh F
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30562. PubMed ID: 37449938
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-Induced Nausea and Vomiting Prophylaxis: Practice Within the Children's Oncology Group.
Patel P; Robinson PD; Orsey A; Freedman JL; Langevin AM; Woods D; Sung L; Dupuis LL
Pediatr Blood Cancer; 2016 May; 63(5):887-92. PubMed ID: 26864262
[TBL] [Abstract][Full Text] [Related]
9. Children's Oncology Group's 2023 blueprint for research: Developmental therapeutics.
Fox E; Parsons DW; Weigel BJ;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30563. PubMed ID: 37430453
[TBL] [Abstract][Full Text] [Related]
10. Children's Oncology Group's 2023 blueprint for research: Young investigators.
Esbenshade AJ; Kahalley LS; Wistinghausen B; Cash T; Baertschiger RM; Zarnegar-Lumley S; Green A; Dhall G;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30567. PubMed ID: 37438856
[TBL] [Abstract][Full Text] [Related]
11. Children's Oncology Group's 2023 blueprint for research: Rare tumors.
Schultz KAP; Chintagumpala M; Piao J; Chen KS; Gartrell R; Christison-Lagay E; Berry JL; Shah R; Laetsch TW;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30574. PubMed ID: 37458616
[TBL] [Abstract][Full Text] [Related]
12. Children's Oncology Group's 2023 blueprint for research: Radiation oncology.
Kalapurakal JA; Wolden SL; Haas-Kogan D; Laack NN; Hua CH; Paulino AC; Hill-Kayser CE; Hoppe BS; Fitzgerald TJ;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30593. PubMed ID: 37486145
[TBL] [Abstract][Full Text] [Related]
13. Children's Oncology Group 2023 blueprint: Nursing discipline.
Zupanec S; Herriage T; Landier W;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30575. PubMed ID: 37470719
[TBL] [Abstract][Full Text] [Related]
14. Children's Oncology Group's 2023 blueprint for research: Pharmacy.
Ostrenga AR; Thackray J; McLearan HH; Mulieri KM; Bisaccia E; Militano O; Dupuis LL; Bernhardt MB;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30581. PubMed ID: 37460409
[TBL] [Abstract][Full Text] [Related]
15. Children's Oncology Group's 2023 blueprint for research: Neuroblastoma.
Bagatell R; DuBois SG; Naranjo A; Belle J; Goldsmith KC; Park JR; Irwin MS;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30572. PubMed ID: 37458162
[TBL] [Abstract][Full Text] [Related]
16. Children's Oncology Group's 2013 blueprint for research: non-Hodgkin lymphoma.
Bollard CM; Lim MS; Gross TG;
Pediatr Blood Cancer; 2013 Jun; 60(6):979-84. PubMed ID: 23255391
[TBL] [Abstract][Full Text] [Related]
17. Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood.
Phillips RS; Friend AJ; Gibson F; Houghton E; Gopaul S; Craig JV; Pizer B
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD007786. PubMed ID: 26836199
[TBL] [Abstract][Full Text] [Related]
18. Standards of nutritional care in pediatric oncology: results from a nationwide survey on the standards of practice in pediatric oncology. A Children's Oncology Group study.
Ladas EJ; Sacks N; Brophy P; Rogers PC
Pediatr Blood Cancer; 2006 Mar; 46(3):339-44. PubMed ID: 15926168
[TBL] [Abstract][Full Text] [Related]
19. Identifying clinical practice guidelines for the supportive care of children with cancer: A report from the Children's Oncology Group.
Seelisch J; Sung L; Kelly MJ; Raybin JL; Beauchemin M; Dvorak CC; Kelly KP; Nieder ML; Noll RB; Thackray J; Ullrich NJ; Cabral S; Dupuis LL; Robinson PD
Pediatr Blood Cancer; 2019 Jan; 66(1):e27471. PubMed ID: 30259647
[TBL] [Abstract][Full Text] [Related]
20. Children's Oncology Group's 2023 blueprint for research: Myeloid neoplasms.
Cooper TM; Alonzo TA; Tasian SK; Kutny MA; Hitzler J; Pollard JA; Aplenc R; Meshinchi S; Kolb EA
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30584. PubMed ID: 37480164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
